OncoDaily
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
OncoDaily
Nov 1, 2023, 18:38 |
Blog
George Kapetanakis: A closed round table discussion "European and National Cancer Strategy: The digital leap towards improving oncology care"
George Kapetanakis, President of the Hellenic Cancer Federation, shared on LinkedIn: "I am thrilled to…
Nov 1, 2023, 18:35 |
Career
Javed Khan: Postdoctoral Fellowship in Machine Learning
Javed Khan, Deputy Branch Chief at Genetics Branch at National Cancer Institute, shared on LinkedIn:…
Nov 1, 2023, 18:31 |
Drugs
David Sebag-Montefiore: We strongly caution against the use of FOLFOX alone applied to the whole PROSPECT trial population
David Sebag-Montefiore shared on LinkedIn: "Delighted to see our letter published in the New England Journal…
Nov 1, 2023, 18:25 |
Insight
Jennifer Lewis: Excited to share national survey results on lung screening eligibility at Rescue Lung meeting!
Jennifer Lewis, Medical Oncologist at Vanderbilt University Medical Center, shared on Twitter: "Excited to share national…
Nov 1, 2023, 15:01 |
Societies
Isabel Rubio: Thanks to all for such an outstanding work for training and recognition
Isabel Rubio, Head of Breast Surgical Oncology at the University Hospital of Navarra, shared on…
Nov 1, 2023, 14:55 |
Insight
Sebastian Schmidt: Declining mortality in lung cancer - a beacon of hope
Sebastian Schmidt, Head of Strategy and Medical Affairs Computed Tomography at Siemens Healthineers, posted on…
Nov 1, 2023, 14:45 |
Blog
Translational Research in Oncology announced the first patient was randomized in the REPLACE (TRIO041) trial
Translational Research in Oncology shared on their LinkedIn page: ''TRIO is happy to announce that…
Nov 1, 2023, 14:40 |
Societies
Sarah Louden: ESMO23 USA in Florida
Sarah Louden, Founder and CEO of Total Health, stated the following on LinkedIn: ''What an…
Nov 1, 2023, 09:54 |
Blog
Toufic Kachaamy: Successful Endoscopic Oncology Special Interest Group Event
Toufic Kachaamy, Chief of Medicine and Director of Gastroenterology at City of Hope, shared on…
Nov 1, 2023, 09:45 |
Insight
Alessandro Inno: A case of a very elderly patient with MET-exon 14 mutant NSCLC with meaningful and durable benefit from first-line tepotinib, with an acceptable safety profile
Nov 1, 2023, 03:26 |
Insight
OncoDaily Highlights from ESMO with Karima Oualla։ Breast Cancer in Neoadjuvant Setting
[embed]https://www.youtube.com/watch?v=S0MaHb2uwAY[/embed] Karima Oualla, MD, MSc is a Professor of Medical Oncology at the Hassan II…
Oct 31, 2023, 23:29 |
Blog
We’re excited to announce our new strategic partnership with Verily - Georgiamune Inc.
Georgiamune Inc. made the following post on LinkedIn: "We’re excited to announce our new strategic…
Oct 31, 2023, 23:19 |
Blog
Bita Fakhri: Loved hearing these brilliant women in lymphoma openly sharing their career paths
Bita Fakhri, Hematologist and Oncologist at the Stanford Department of Medicine made the following post…
Oct 31, 2023, 23:08 |
Blog
Lizeth Meza: Thrilled to share this project that started during my PhD with Dr. Nicholas Huntington
Lizeth Meza, Research Officer at Walter and Eliza Hall Institute, made the following post on…
Oct 31, 2023, 16:29 |
Opinion
Roupen Odabashian: This book belongs to one person - the patient
Roupen Odabashian, Hematology and Oncology Fellow at Karmanos Cancer Institute, shared on LinkedIn: ''Medical notes…
Oct 31, 2023, 16:25 |
Career
Christine McIver: In the spring of 2024, I am retiring from Kids Cancer Care
Christine McIver, Founder & Chief Executive Officer at Kids Cancer Care Foundation of Alberta, recently…
Oct 31, 2023, 16:15 |
Insight
Svetlana Nikic: Congratulations to the scientific committee for an excellent ESMO 2023
Svetlana Nikic, Founder of Precision Oncology Consulting, shared on her LinkedIn: "Congratulations to the scientific committee…
Oct 31, 2023, 16:13 |
Societies
Thank you to our amazing ambassadors - World SIOP
World SIOP shared on their Twitter page: "Thank you to our amazing ambassadors who supported…
Oct 31, 2023, 16:08 |
Blog
Laura Esfeller: Fantastic opportunity for Latino cancer patient advocates
Laura Esfeller, Director of Marketing Services at San Manuel Band of Mission Indians, shared on…
Oct 31, 2023, 16:04 |
Positive
Our goal has always been to make a real difference in the lives of single mothers with MBC - Infinite Strength
According to a tweet from the Twitter account Infinite Strength: ''We have found that 6…
Oct 31, 2023, 15:58 |
Blog
Kirsty Duncan: Research is a public good that we must all protect
Kirsty Duncan shared on Twitter: "Research is a public good that we must all protect. Canada…
Oct 31, 2023, 15:52 |
Societies
European Society of Pathology collaborates in a new MSc programme, the European Master Molecular Pathology
European Society of Pathology shared on LinkedIn: "European Society of Pathology is dedicated to providing…
Oct 31, 2023, 15:46 |
Blog
Toufic Kachaamy: Success is not just about groundbreaking discoveries, but in the collaboration and unity of minds
Toufic Kachaamy, Enterprise Clinical Leader and Interventional Program Specialist at City of Hope, stated the…
Oct 31, 2023, 15:43 |
Career
Andres Moreno-Estrada: First time I get the cover of a magazine and it's in Nature!
Andres Moreno-Estrada, Professor and Head of the Genome Core Facility (LANGEBIO) Employment, shared Twitter: "First…
Oct 31, 2023, 15:38 |
Insight
Susan Pandya: U.S. FDA approval of our targeted therapy underscores the efforts of our exceptional clinical research team
Susan Pandya, Vice President of Clinical Development and Global Head of Cancer Metabolism at Servier…
Oct 31, 2023, 15:37 |
Blog
Paolo A. Ascierto: I owe it every day to Giuseppe, to Carla, to Rosina, to Gabriele, to the many who are still part of that 50% who are less lucky
Quoting Paolo A. Ascierto, Director Department of Melanoma, Cancer Immunotherapy, Development Therapeutics at the National…
Oct 31, 2023, 15:33 |
Career
Raj Panjabi: I was honored to receive the Public Service Award from The Johns Hopkins University's Alumni Association
Raj Panjabi, Entrepreneur in Residence at Emerson Collective, recently posted on LinkedIn. "On Friday, I…
Oct 31, 2023, 15:12 |
Opinion
Gevorg Tamamyan: Let me remain human
Gevorg Tamamyan, the Editor-in-Chief of OncoDaily and the Head of the Pediatric Cancer and Blood…
Oct 31, 2023, 10:35 |
Career
Heidi Russell has been appointed Director of the UTHealth Houston School of Public Health's Dual Degree Programs. -UTHealth Houston School of Public Health
The University of Texas Health Science Center at Houston (UTHealth) School of Public Health recently shared…
Oct 31, 2023, 10:34 |
Blog
Hongcheng Zhu: Awarded Master of Molecular Oncology by Center for Biosanitary Studies in Madrid.
Hongcheng Zhu, Radiation oncologist at Fudan University Shanghai Cancer Center, China, shared a post on…
Oct 31, 2023, 10:33 |
Insight
Andrew M Wardley: Immediate action is essential to save our dedicated over worked clinicians
Andrew M Wardley, Chair of the Association of Cancer Physicians, recently shared a post by…
Oct 31, 2023, 10:31 |
Blog
George Yaghmour: We dance for cure and awareness
George Yaghmour, Associate Director of USC Norris Blood and Marrow Transplant Program at University of…
Oct 31, 2023, 10:30 |
Career
Fumiko Ladd Chino: Eniola Otukoya presented her Conquer Cancer, the ASCO Foundation merit award winning work at ASCOQLTY23
Fumiko Ladd Chino recently posted on X/Twitter: "Student doc Eniola Otukoya presented her Conquer Cancer,…
Oct 31, 2023, 10:23 |
Blog
Harout Semerjian: It was an honor to be appointed to the Biotechnology Innovation Organization’s Board of Directors, Emerging Companies Section
Harout Semerjian, President and CEO at GlycoMimetics, posted on LinkedIn: "It was an honor this…
Oct 31, 2023, 10:22 |
Insight
5 Decades of Impact reflection series - Australasian Leukaemia and Lymphoma Group
Australasian Leukaemia and Lymphoma Group (ALLG) shared on their LinkedIn: "To mark the start of…
Oct 31, 2023, 10:21 |
Career
Joel Helmke: Honoring exceptional nurses from across Pennsylvania
Joel Helmke, Chief Operating Officer at Fox Chase Cancer Center, shared on LinkedIn: "Honoring exceptional…
Oct 31, 2023, 10:20 |
Blog
Jeremy Slone: The first pediatric hematology-oncology hospitalist conference at St. Jude Children's Research Hospital
Jeremy Slone shared on LinkedIn. "The first pediatric hematology-oncology hospitalist conference at St. Jude Children's…
Oct 31, 2023, 10:11 |
Blog
Yao Yu: Happy to share our work on Stereotactic radiosurgery with concurrent Antibody Drug Conjugates
Yao Yu, Radiation Oncologist at Memorial Sloan Kettering Cancer Center, shared on X/Twitter: "Happy to…
Oct 31, 2023, 10:03 |
Blog
Japheth J. Omojuwa: Nigeria’s biggest cancer awareness walk in Abuja today
Quoting Japheth J. Omojuwa, a Nigerian writer on X/Twitter: "It was such a pleasure and…
Oct 31, 2023, 09:57 |
Blog
Matthias Guckenberger: Virtual Grand Rounds in Radiation Oncology
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X/Twitter: "Approaching quickly: Virtual Grand…
Oct 31, 2023, 09:53 |
Dialogues
OncoDaily Walk and Talk with Philip Philip and Celine Philip, Hosted by Tatev Margaryan
We continue to Walk & Talk with world-renowned oncologists, and today, our guests were Dr…
Oct 31, 2023, 09:51 |
Blog
Marleah Dean Kruzel: ASRM webinar on Hereditary Cancer and family building
Marleah Dean Kruzel, Associate Professor at University of South Florida, shared a post by ASRM…
Oct 31, 2023, 09:50 |
Blog
Rasha Aboelhassan: Discussion of metastatic Colorectal Cancer during Egyptian Gastro-hepto Oncology summit
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn: “I'm so…
Oct 31, 2023, 09:44 |
Blog
Claire Albano: Three ways digitalization is improving healthcare
Claire Albano, Director of European Government Affairs at Bristol Myers Squibb, shared on LinkedIn: “How…
Oct 31, 2023, 09:39 |
Insight
Paolo A. Ascierto: The history of melanoma is changing!
Paolo A. Ascierto, Director Department of Melanoma/Skin Cancers, Cancer Immunotherapy and Development Therapeutics at IRCCS,…
Oct 31, 2023, 04:25 |
Dialogues
5min OncoDaily Updates with Chandler Park: Dr. Yüksel Urun on practice changing CheckMate 901 study for bladder cancer patients
[embed]https://www.youtube.com/watch?v=5qJ8T2SFHOA[/embed]
Oct 30, 2023, 19:47 |
Opinion
Jeniece Waite: Agenus is hiring clinical scientists
Jeniece Waite, Senior Recruiting Manager at Agenus, shared a post on LinkedIn: "As a Clinical…
Oct 30, 2023, 19:41 |
Blog
Calling all European medical students to join us for the very first SIOP Europe Student Summer School for Paediatric Oncology - SIOPE
SIOP Europe, the European Society for Paediatric Oncology - SIOPE shared a post on X/Twitter: "Calling…
Oct 30, 2023, 19:30 |
Stories
We're highlighting Imani’s story and her full circle moment from pediatric Blood Cancer patient to nurse - The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society shared a post on Linkedin: "'I was diagnosed with myelodysplastic syndrome…
Oct 30, 2023, 19:21 |
Blog
Amer Zeidan: A watershed moment for Myelodysplastic syndromes
Amer Zeidan, shared a post on LinkedIn: "A watershed moment for Myelodysplastic syndromes with the first approval…
Oct 30, 2023, 19:12 |
Stories
Nina Balanchivadze: Stacy's story is a testament to the power of hope, the strength of the human spirit, and the impact that cutting-edge science can have on lives
Nina Balanchivadze, Hematologist/Oncologist at Virginia Oncology Associates, shared a post on LinkedIn: "I am privileged…
Oct 30, 2023, 19:06 |
Blog
Diana Romero: How timely of us at Nature Reviews Oncology to publish a piece on financial toxicity the day after ESMO 23 finishes
Diana Romero shared a post by Nature Reviews Oncology on X/Twitter: “How timely of us at…
Oct 30, 2023, 18:52 |
Blog
Alvaro Lassaletta: Promising results just published with MEMMAT in relapsed medulloblastoma
Alvaro Lassaletta, Coordinator of the Brain Tumor Unit at Hospital Niño Jesús, shared a post…
Oct 30, 2023, 18:42 |
Blog
Henry Yau: Clinical Trials Centre, The University of Hong Kong (HKU-CTC) is celebrating the 25th anniversary
Henry Yau, Chief Executive Officer at HKU Clinical Trial Centre (China), shared a post on…
Oct 30, 2023, 18:24 |
Blog
Henriette Neumeyer: At IHF Congress 2023, I was deeply honored to discuss Clinical Leadership
Henriette Neumeyer, Vice Chair of The Board German Hospital Federation, shared a post on Link:…
Oct 30, 2023, 18:16 |
Blog
Sean Lybrand: I was very pleased to meet with World Child Cancer Board Member Julie S. Torode
Sean Lybrand, Executive Director at Amgen, shared on LinkedIn: "During the week of World Child…
Oct 30, 2023, 18:15 |
Blog
Ane Gerda Zahl Eriksson: So grateful for the generosity of Ida Øye Bjørkvold supporting our research on women with cervical cancer
Ane Gerda Zahl Eriksson, Gynecologic Oncologist at Norwegian Radium Hospital, shared on X/Twitter: "So grateful for…
Oct 30, 2023, 18:10 |
Blog
Amar Gajjar: We brought investigators together to unpack the future of brain tumour research and care
Quoting Amar Gajjar, Pediatric Neuro-Oncologist at St. Jude Children’s Research Hospital, on X/Twitter: "Moving from…
Oct 30, 2023, 18:05 |
Blog
Katie Coleman: If you can’t find the moments, make them
Katie Coleman, Founder of Chromophobe and Oncocytic Tumor Alliance (COA), shared on X/Twitter: "If you…
Oct 30, 2023, 17:58 |
Blog
In conflict situations, we go where people’s needs are greatest - Médecins Sans Frontières (MSF) Canada
Quoting Doctors Without Borders/Médecins Sans Frontières (MSF) Canada on LinkedIn: "We are an international emergency…
Oct 30, 2023, 17:51 |
Blog
Krishna Komanduri: I’m so lucky to be a cell therapist
Quoting Krishna Komanduri, Physician-in-Chief at the Helen Diller Family Comprehensive Cancer Center, on LinkedIn: "Today was…
Oct 30, 2023, 17:42 |
Blog
Apply for UICC's Yamagiwa-Yoshida Memorial International Cancer Study Grants
Quoting Union for International Cancer Control (UICC) on LinkedIn: "Apply for UICC's Yamagiwa-Yoshida Memorial International…
Oct 30, 2023, 17:35 |
Blog
Gvantsa Khizanishvili: I spent time in Greater Petaling, for the key milestone meetings with the technical and executive teams
Gvantsa Khizanishvili, Global Programme Manager and Acting Regional Director Asia at City Cancer Challenge, shared…
Oct 30, 2023, 13:42 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023
Starting from August 26, which is Women’s Equality Day in the United States—celebrating the 1920…
Oct 30, 2023, 07:49 |
Blog
Tedros Adhanom Ghebreyesus: Alf Mabrouk Hanan Balkhy for being elected to serve as the first female WHO Regional Office for the Eastern Mediterranean (EMRO) Regional Director
Oct 30, 2023, 07:33 |
Blog
Sebastian Werngreen Nielsen: This weekend I had the privilege of attending the ESMO 2023 conference in Madrid as an invited speaker and poster presenter
Quoting Sebastian Werngreen Nielsen, MD at Rigshospitalet Copenhagen University Hospital, on LinkedIn: "This weekend I…
Oct 30, 2023, 07:19 |
Blog
Patricia LoRusso has received the AACI 2023 Distinguished Scientist Award - Yale Cancer Center
Yale Cancer Center recently posted on LinkedIn, "Patricia LoRusso has received the AACI (Association of…
Oct 30, 2023, 07:13 |
Blog
The Institute of Cancer Research has ranked as one of the UK's best higher education institutions at engaging with industry, academic partners and the wider public - The Institute of Cancer Research
Oct 29, 2023, 17:56 |
Blog
Vincent Rajkumar: When you grant a for-profit company monopoly rights to a life-saving drug, you must set a ceiling on the price to protect the public— common sense
Quoting Vincent Rajkumar, Editor-in-Chief of the Blood Cancer Journal, on X/Twitter: "When you grant a…
Oct 29, 2023, 17:50 |
Blog
Humaid Al-Shamsi: We are delighted to announce the condensed version of the ESMO Conference in Dubai next month
Humaid Al-Shamsi, Director of Burjeel Cancer Institute (BCI) Comprehensive Cancer Center, shared on LinkedIn: "We…
Oct 29, 2023, 17:44 |
Blog
Pet therapy for Pediatric Hematology-Oncology patients! - Italian Association of Pediatric Hematology and Oncology (AIEOP)
Italian Association of Pediatric Hematology and Oncology (AIEOP) shared on LinkedIn: "Pet therapy for Pediatric Hematology-Oncology patients!…
Oct 29, 2023, 17:37 |
Opinion
Mark Lanasa: The data we presented at ESMO are only the beginning of our story in solid tumors
Mark Lanasa, Chief Medical Officer of Solid Tumors at BeiGene, shared on LinkedIn: "I had…
Oct 29, 2023, 17:31 |
Insight
Diego Adrianzen-Herrera: Our study on MDS and autoimmune disease in Blood Advances
Diego Adrianzen-Herrera, Assistant Professor of Medicine UVM Larner Med, shared a post on Twitter, saying: "Our…
Oct 29, 2023, 17:23 |
Career
IASLC welcomes Jennifer C. King as the new Chief Science Officer
The International Association for the Study of Lung Cancer (IASLC) shared a post on Twitter:…
Oct 29, 2023, 17:14 |
Career
Nadine J. Barrett joins Wake Forest University School of Medicine and Atrium Health as Senior Associate Dean for Community Engagement and Equity in Research
Wake Forest University School of Medicine shared on LinkedIn: ''Exciting News! We are thrilled to…
Oct 29, 2023, 17:07 |
Blog
David Fredrickson: When it comes to driving breakthroughs in cancer care, curiosity is a superpower
David Fredrickson, Executive Vice-President of Oncology Business at AstraZeneca, shared a post on LinkedIn: "When…
Oct 29, 2023, 16:57 |
Blog
Gvantsa Khizanishvili: City Cancer Challenge growing network are open until 15 January 2024 for cities with over 1 million inhabitants
Gvantsa Khizanishvili, Acting Regional Director for Asia at City Cancer Challenge, on LinkedIn: "I am…
Oct 29, 2023, 16:16 |
Dialogues
5 min OncoDaily Updates with Chandler Park: Dr. Grivas on the 1st clinical study of 2 different antibody drug conjugates
[embed]https://www.youtube.com/watch?v=kc06AUL3gCA[/embed]
Oct 29, 2023, 04:04 |
Blog
Ify Osunkwo: We invite you to join our interactive roundtable discussion
Ify Osunkwo, Chief Patient Officer at Novo Nordisk, shared on LinkedIn: "A rare opportunity for…
Oct 29, 2023, 03:56 |
Insight
Enrique Soto: The new ASCO and ESMO global curriculum recommendations for Cancer Care in older adults
Enrique Soto, Medical Oncologist at the National Institute of Medical Science and Nutrition in Mexico…
Oct 29, 2023, 03:52 |
Blog
Karen Knudsen: Black women are 40% more likely to die from breast cancer, despite lower incidence than White women
Karen Knudsen shared on LinkedIn: "Black women are 40% more likely to die from breast…
Oct 29, 2023, 03:47 |
Blog
Applications are now open for the 2024 Flagship Pioneering Summer Fellowship
Flagship Pioneering shared on their LinkedIn page: ''Applications are now open for the 2024 Flagship…
Oct 29, 2023, 03:42 |
Blog
Diogo Martins Branco: RWE of surgery of the primary tumor in patients with de novo metastatic breast cancer
Diogo Martins Branco, Board Member at AICSO, shared a post on LinkedIn: ''Hot off the…
Oct 29, 2023, 03:39 |
Opinion
Sachin H. Jain: Ethical erosion exists all around us
Sachin H. Jain, President and CEO of Scan Group and Health Plan, posted on LinkedIn: "Ethical…
Oct 29, 2023, 03:34 |
Drugs
Steven O'Day: The research we shared underscores BOT’s broad potential utility across multiple advanced solid tumors
Steven O'Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "It was an exciting…
Oct 29, 2023, 03:27 |
Blog
Nick Guldemond: We discussed the reconstruction of the medical infrastructure in Ukraine
Nick Guldemond, Professor of Integrated Care and Technology, CEO and founder of Medical Field Lab,…
Oct 29, 2023, 03:16 |
Drugs
Antonio Passaro: I was honored to present in Presidential, the primary results of the global randomized phase 3 study MARIPOSA-2
Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared on LinkedIn: "ESMO23 is…
Oct 29, 2023, 03:04 |
Career
Nick Odom: Congrats Abby Rosenberg, the 2023 American Cancer Society Pathfinder in Palliative Care Award
Abby Rosenberg, Chief of Pediatric Palliative Care at Dana-Farber Cancer Institute, shared a post by…
Oct 29, 2023, 02:58 |
Blog
Celine Surmont-Francina: The call for sessions for the World Cancer Congress 2024 is now OPEN!
Celine Surmont-Francina, Head of Congress and Events at Union for International Cancer Control, shared on…
Oct 29, 2023, 02:53 |
Blog
Aaron Goodman: Teaching the fellows and new attendings how to use Twitter to their advantage
Aaron Goodman shared on Twitter: “Teaching the fellows and new attendings how to use Twitter…
Oct 28, 2023, 16:36 |
Insight
Vinay Prasad: The most interesting thing you'll read about PFS, EFS, DFS in oncology this year
Vinay Prasad, Professor of Epidemiology and Biostatistics at University of California, shared a post by…
Oct 28, 2023, 16:09 |
Career
Julia Hoveyan: Maybe tomorrow that brain tumor will be curable, and we need to do our best to achieve that
Julia Hoveyan, Pediatric oncologist at the Pediatric Cancer and Blood Disorders Center of Armenia, shared…
Oct 28, 2023, 16:01 |
Blog
Amalya Sargsyan: Prof. Carol Greider won a NOBEL PRIZE but NIH rejected her grant on the same day!
Amalya Sargsyan, Research Fellow at Immune Oncology Research Institute, shared a post on Twitter: "At…
Oct 28, 2023, 15:53 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 10
Our 2023 OncoDaily series on '100 Influential Women in Oncology: Key Opinion Leaders to Follow…
Oct 28, 2023, 15:52 |
Blog
Frances Davis: The NIH will be attending the 37th Annual Conference this upcoming weekend!
Frances Davis, Human Resources Specialist at National Institute of Health, shared a post on LinkedIn:…
Oct 28, 2023, 15:40 |
Blog
The beginning of International Cancer Week, focusing on “Addressing Cancer Care Disparities through Research and Improved Access to Treatment.” - MEDICAID CANCER FOUNDATION
Oct 28, 2023, 15:34 |
Blog
Andreas A. Argyriou: Honoured to be an invited speaker at the Madrid ESMO 2023 and present about chemotherapy-induced central neurotoxicity
Andreas A. Argyriou, Neurology Medical Director at Agios Andreas State General Hospital, shared a post o…
Oct 28, 2023, 15:29 |
Career
Miriam Sabin: The North American Office of The Lancet is hiring a Senior Editor
Quoting Miriam Sabin, North American Executive Editor at the Lancet, on LinkedIn: ''Dear All, The…
Oct 28, 2023, 15:23 |
Insight
Bente Mikkelsen: How to formulate a global response to cancer through partnership and co-creation
Quoting Bente Mikkelsen, Director of the Non-Communicable Diseases Department at the World Health Organization, on…
Oct 28, 2023, 11:36 |
Blog
Stephanie Graff: The relationship of PIM1 and metastatic breast cancer, potential therapeutic implications with CDK4/6 inhibitors and more!
Quoting Stephanie Graff on LinkedIn: ''That’s a wrap on the 2023 European Society of Medical…
136
137
138
139
140
All:
16186
Posts:
13701 - 13800
Why does Lionel Messi donate so much to charity?
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Facebook
RSS Feed
Twitter
Linkedin
Youtube